Latest Loan Facilities News

De.mem Limited has closed a $500,000 unsecured shareholder loan facility to fund the rapid expansion of its recently acquired Core Chemicals business amid strong demand from the gold mining sector.

Cann Group Limited has successfully completed a significant debt restructure and equity raising, improving its financial footing and liquidity to support future growth.

Westgold Resources is set to demerge its non-core Reedy and Comet gold projects into a new ASX-listed entity, Valiant Gold, aiming to unlock value and fast-track cash flow through a strategic ore purchase agreement.

Korab Resources Limited reported a positive cash flow for the December 2024 quarter, maintaining a strong liquidity position with funding to support its exploration activities for over 17 quarters.

Amaero Ltd has secured a substantial A$9 million saving on its Argon recycling plant, ordered a fourth atomizer to boost U.S. powder production, and remains on track with its A$72 million capital investment program.

Dalrymple Bay Infrastructure has secured $1.07 billion in new loan facilities, slashing its borrowing costs and extending debt maturity while maintaining its investment grade rating.

Anax Metals has completed a $2.4 million strategic placement with mining group Gold Valley at a 37.5% premium, while securing a $3.5 million loan to repay convertible notes, positioning the Whim Creek copper project for near-term development.

Ainsworth Game Technology forecasts a slight decline in full-year profit driven by weaker North American sales in the second half, despite revenue growth in Asia-Pacific and Latin America.

Matrix Composites & Engineering has fully redeemed its $7.5 million convertible note, replacing it with a new term loan facility from NAB that offers improved terms and a streamlined debt structure.

Scout Security has made significant strides toward merging with Roo Inc, secured $600,000 in fresh capital, and progressed a new Insurtech partnership, all while managing tight cash flow in the September quarter.

EQ Resources Limited has successfully raised $34 million through a share placement, aiming to accelerate development at its Carbine Vein project and strengthen its balance sheet amid robust tungsten market conditions.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.